Karagöz Ahmet, Kesici Sevgi, Vural Aslı, Usta Murat, Tezcan Berna, Semerci Tuna, Teker Erhan
Department of Cardiology, Faculty of Medicine, Giresun University; Giresun-Turkey.
Department of Anesthesiology and Reanimation, Faculty of Medicine, Giresun University; Giresun-Turkey.
Anatol J Cardiol. 2016 Dec;16(12):923-930. doi: 10.14744/AnatolJCardiol.2016.6780. Epub 2016 Jun 29.
Viscum album L. has favorable cardiovascular effects including antihypertensive and vasorelaxant activity, and the nitric oxide (NO) pathway upregulation has been proposed to be the underlying mechanism. NO also plays an important role in the pathophysiology of heart failure. However, its effects on cardiac systolic function are unclear.
A total of 30 male Wistar albino rats at 12 weeks of age were randomly divided into three groups: control, isoproterenol-induced heart failure group (ISO), and isoproterenol-induced heart failure + V. album treatment group (VA) groups (n=10 in each group). V. album was orally given at a dose of 250 mg/kg/day by gavage. Parameters of heart failure were compared among the groups. Tamhane's T2 test, paired sample t-test, and Bonferroni methods were used for statistical analysis.
V. album resulted in an improvement in all parameters of heart failure including left ventricular diameters (6.34±0.23 mm, 6.98±0.35 mm, and 6.71±0.10 mm for left ventricular end-diastolic diameter in control, ISO, and VA groups, respectively, p<0.05), ejection fraction (73.3±3.1%, 56.7±2.6%, and 65.2±1.5% for control, ISO, and VA groups, respectively, p<0.05), serum NT-proBNP levels, and histopathological changes. V. album treatment resulted in a statistically significant attenuation of increased levels of NO and iNOS (p<0.0001). The levels of hs-CRP were also found to be lower in the VA group compared with the controls and ISO groups (p<0.01).
V. album exerted favorable effects on left ventricular function in isoproterenol-induced heart failure rats. Upregulation of the NO pathway seems to be the possible pathophysiological mechanism. Favorable vascular outcomes can also be speculated considering the reduction in serum hs-CRP levels.
白果槲寄生具有良好的心血管效应,包括降压和血管舒张活性,有人提出一氧化氮(NO)途径上调是其潜在机制。NO在心力衰竭的病理生理学中也起重要作用。然而,其对心脏收缩功能的影响尚不清楚。
将30只12周龄的雄性Wistar白化大鼠随机分为三组:对照组、异丙肾上腺素诱导的心力衰竭组(ISO)和异丙肾上腺素诱导的心力衰竭+白果槲寄生治疗组(VA)(每组n = 10)。通过灌胃以250 mg/kg/天的剂量口服白果槲寄生。比较各组心力衰竭参数。采用Tamhanes T2检验、配对样本t检验和Bonferroni方法进行统计分析。
白果槲寄生使心力衰竭的所有参数均得到改善,包括左心室直径(对照组、ISO组和VA组的左心室舒张末期直径分别为6.34±0.23 mm、6.98±0.35 mm和6.71±0.10 mm,p<0.05)、射血分数(对照组、ISO组和VA组分别为73.3±3.1%、56.7±2.6%和65.2±1.5%,p<0.05)、血清NT-proBNP水平和组织病理学变化。白果槲寄生治疗导致NO和诱导型一氧化氮合酶(iNOS)水平升高的统计学显著降低(p<0.0001)。还发现VA组的超敏C反应蛋白(hs-CRP)水平低于对照组和ISO组(p<0.01)。
白果槲寄生对异丙肾上腺素诱导的心力衰竭大鼠的左心室功能有良好影响。NO途径上调似乎是可能的病理生理机制。考虑到血清hs-CRP水平降低,也可以推测有良好的血管结局。